CTV and OTT Advertising for Healthcare: A Buyer's Guide

Most pharma and health system teams now have streaming TV somewhere in the plan. Sometimes it is a test line carved out of the linear budget. Sometimes it is the largest single video line. What varies a lot is how well the team understands what it is buying, which data is attached to each impression, and what the measurement can and cannot prove. This guide is the starting point for a series on healthcare CTV, OTT, and TV measurement. Each section points to a more detailed article.

What CTV and OTT mean in healthcare advertising

CTV, connected TV, is the screen. It is a television that reaches the internet through a smart TV operating system, a streaming stick, a game console, or a cable operator's set-top box with an app layer. OTT, over the top, is the delivery method: video sent over the internet rather than through a cable or satellite signal. OTT impressions can land on a TV, a phone, a tablet, or a laptop.

In practice the terms blur. A publisher selling "OTT" may be reporting a blend where 70 percent of impressions run on TV screens and the rest on mobile. A DSP line labeled "CTV" should be TV screens only, but device detection is not perfect. The first thing I would ask any partner is the device split on delivered impressions, because a 30 second spot with a long major statement plays very differently on a 65 inch screen in the living room than on a phone held vertically on a train.

Healthcare adds its own vocabulary on top. DTC pharma uses CTV to build awareness and drive branded search. Health systems use it for service line campaigns in specific DMAs. A few brands use it to reach physicians at home, which is covered in CTV for HCPs and how NPI to household matching works.

How healthcare brands buy CTV

There are four common routes, and most brands use more than one.

The route matters more than the CPM. Two impressions on the same show can arrive through a direct deal, a reseller, and an open auction bundle, each at a different price and with different transparency. That is why supply checks (ads.txt, sellers.json, and the app bundle) belong in the plan before launch. The existing pharma CTV supply chain audit walks through those checks, and how to compare syndicated reach across CTV partners covers what happens when the same inventory shows up through several sellers.

Free ad-supported streaming channels and the newer ad tiers on subscription services are now large parts of the supply. They are not interchangeable. Content quality, ad load, and frequency control differ by service. See FAST channels and ad-supported streaming tiers for pharma for how to evaluate them.

Targeting options for healthcare CTV

Targeting on CTV is almost always household targeting. The TV is shared, so even a perfectly matched household includes people who are not the intended viewer. That is fine for most DTC goals and a real limitation for anything that assumes one person in front of the screen.

The usual options, from least to most sensitive:

• Demographic and geographic. Age, income bands, DMA or ZIP clusters. Low privacy risk, high waste for niche conditions.
• Contextual and content-genre. Health and wellness programming, news, daytime, specific networks. Content signals on CTV are coarser than on the web because many apps pass only genre or show-level metadata, if that.
• Modeled health-interest segments. Households scored for likely interest in a condition category. These come from data providers and need provenance and consent review, especially with state consumer health data laws such as Washington's My Health My Data Act.
• First-party and CRM matches. Patient support enrollees or opt-in lists matched to households. Strongest consent questions and often the smallest scale.
• HCP at home. Physician households matched from NPI lists. Small, expensive, and mostly useful as frequency support for other HCP channels.

All of these depend on a household graph that links IP addresses, devices, and postal addresses. Graph quality drives match rates, spillover into non-target households, and how much of your "targeted" spend actually lands where you intended. CTV household graphs and healthcare audience targeting covers how those graphs are built and how to test them.

What drives CTV pricing for pharma

CTV CPMs vary widely, and the list price of a deal is a poor guide to what you will actually pay per useful impression. The main drivers:

1. Content tier. Live sports and premium originals cost more than library content or FAST channels.
2. Data fees. Every audience segment layered on a CTV line adds a data CPM, and healthcare segments are usually priced at a premium.
3. Targeting narrowness. Smaller audiences mean higher bids to win the impressions that exist, and more competition from other brands chasing the same households.
4. Guarantees and makegoods. Guaranteed delivery and audience guarantees cost more than non-guaranteed.
5. Measurement add-ons. Third-party verification, reach measurement, and outcomes studies are separate fees that sit outside the media CPM.

A hypothetical example: a direct deal at a $40 CPM with no data, reaching a broad adult audience where 20 percent of households fit the condition profile, costs $200 per thousand target households. A programmatic line at $55 all-in (media plus data) where 50 percent of households fit costs $110 per thousand target households. The cheaper CPM is the more expensive buy. The reverse also happens when the data segment is thin and the "targeted" line is mostly modeled guesses. The same logic holds in display, where a cheap CPM often hides an expensive outcome.

Shifting budget from linear TV to CTV

The linear versus CTV decision for pharma is not ideological. Linear still reaches older audiences at scale and many conditions skew older. CTV gives targeting, frequency control, and faster optimization, but reach on any single streaming service is fragmented. The question is how much of your audience you can no longer reach efficiently on linear, and whether your measurement can show what CTV adds. Linear TV vs. CTV for pharma DTC gives a decision table built around age skew, condition size, and creative length.

Creative and compliance rules specific to healthcare CTV

Product claim ads for prescription drugs on TV must include a major statement of the most important risks in the audio, and FDA's rule on presenting the major statement in a clear, conspicuous, and neutral manner (finalized in 2023) added requirements such as presenting it in both audio and text at the same time. As of 2026 you should check the current regulation text and your regulatory team's interpretation before assuming streaming is treated differently from broadcast. In practice most teams treat CTV spots as TV spots for compliance purposes.

That has a direct effect on media. A 15 second spot cannot fit a full major statement for most products, so 15s units are usually reminder or unbranded help-seeking. Many CTV buys default to 15s and 30s pods. If your approved asset is a 60 or 75, confirm the publisher accepts that length before signing. Interactive units, QR codes, and pause ads raise their own MLR questions. Pharma CTV creative: length, fair balance, and interactive formats covers the tradeoffs.

How to measure CTV for healthcare brands

Measurement has three layers, and most reporting problems come from mixing them.

For reach, the method behind the number matters as much as the number. Panel-based, ACR-based, and server-data approaches handle device deduplication differently, which is why two providers can report reach figures 30 percent apart for the same campaign. How CTV measurement providers differ on reach, frequency, and device deduplication explains why. If the plan includes linear TV and online video too, read measuring reach and frequency across linear TV, CTV, and online video and the existing guide on deduplicated reach across CTV and online video.

For outcomes, the honest answer usually comes from a controlled design: a holdout of households, a geo test, or a ghost-ad comparison inside a platform. Tools for measuring CTV incrementality compares the methods and what each needs to work. The older piece on testing incrementality in pharma CTV covers test design in more depth.

What usually goes wrong

A few patterns show up again and again in healthcare CTV plans:

• The approved spot length does not match the inventory bought, and the brand ends up running a shorter unbranded cut on a line planned for product claims.
• Frequency caps are set per line, so a household sees the same spot 15 times across four sellers. Frequency has to be managed across sellers, not per line.
• Reach is reported by each partner separately and then added together in a deck.
• Outcomes vendors report attributed new-to-brand prescriptions, and the team treats them as incremental.
• Data segments are approved by media but never reviewed by privacy or legal for state law exposure.

None of these are exotic. They happen because CTV sits between the TV team and the digital team, and each assumes the other is handling the hard part. The broader pharma CTV advertising guide and the healthcare video strategy across CTV, online video, and YouTube cover how CTV fits next to the other video channels.

Practical takeaway

Before the next CTV flight, write a one-page plan that names, for each line, the buying route, the device split you expect, the approved spot length, the targeting data and who reviewed it, and which of the three measurement layers will report on it. If any line has a blank, fix that before negotiating price.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.